Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126663671 | 12666367 | 1 | I | 201511 | 20160810 | 20160818 | 20160818 | EXP | DK-ASTRAZENECA-2016SE86116 | ASTRAZENECA | 55.00 | YR | F | Y | 0.00000 | 20160819 | CN | DK | DK |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126663671 | 12666367 | 1 | PS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 5.0MG UNKNOWN | N | 21366 | 5 | MG | TABLET |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126663671 | 12666367 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126663671 | 12666367 | Diplopia | |
| 126663671 | 12666367 | Dizziness | |
| 126663671 | 12666367 | Dyspnoea | |
| 126663671 | 12666367 | Neuropathy peripheral | |
| 126663671 | 12666367 | Peripheral swelling | |
| 126663671 | 12666367 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126663671 | 12666367 | 1 | 201607 | 0 |